Drug Approvals
🇺🇸 FDA Page 16FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 181–192 of 665 articles
Elite Pharma Files FDA ANDA for $26B Generic Blood Thinner, Targeting Key Anticoagulant Market
Rallybio Pursues Reverse Merger with Avenzo Therapeutics to Advance Autoimmune Pipeline
Obefazimod: Abivax Ulcerative Colitis Drug Faces Efficacy vs. Safety Scrutiny
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect Program
Rigel Pharmaceuticals Licenses FDA-Approved Breast Cancer Drug VEPPANU
Accelerating Drug Development: FDA's AI Clinical Trials RFI Guide
FDA Leadership Changes: Implications for the Pharmaceutical Industry
Tech Initiatives at Summa Health Post-General Catalyst Acquisition
2026 Orphan Drugs Report: Navigating Challenges Ahead
Ultra-Low Doses: A Game Changer for Cancer Treatment Access
RevMed's Triumph and Akeso's Caution: Insights from STAT+
Revolution Medicines' Pancreatic Cancer Drug: Practice-Changing Results